Stay updated on Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Sign up to get notified when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.

Latest updates to the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows a new revision tag v3.4.2 and removes the previous revision v3.4.1; core study details, eligibility criteria, and results remain unchanged.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. There are no visible changes to study details content or page layout.SummaryDifference0.1%

- Check41 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, reflecting a minor administrative update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedLocations section updated to include Seoul, Korea, Republic of as a study site. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.3%

- Check91 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. This appears to be a minor labeling update with no changes to study content or page functionality.SummaryDifference0.1%

- Check99 days agoChange DetectedThe government funding status notice was removed from the page, and this does not affect trial details, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: AZD6094 + Docetaxel in MET+ Gastric Cancer page.